Table of Contents

Articles

• Open Access

  Neoplasia-associated Chromosome Translocations Resulting in Gene Truncation

  IOANNIS PANAGOPOULOS and SVERRE HEIM

  Cancer Genomics & Proteomics November 2022, 19 (6) 647-672; DOI: https://doi.org/10.21873/cgp.20349
• Open Access

  Inverse Correlation of KISS1 and KISS1R Expression in Triple-negative Breast Carcinomas from African American Women

  MUSTAFA QASIM, LUISEL J. RICKS-SANTI, TAMMEY J. NAAB, FAREED RAJACK, DESTA BEYENE, MUNEER ABBAS, OLAKUNLE O. KASSIM, ROBERT L. COPELAND and YASMINE KANAAN

  Cancer Genomics & Proteomics November 2022, 19 (6) 673-682; DOI: https://doi.org/10.21873/cgp.20350
• Open Access

  Oral Installation of Recombinant Methioninase-producing Escherichia coli into the Microbiome Inhibits Colon-cancer Growth in a Syngeneic Mouse Model

  YUTARO KUBOTA, QINGHONG HAN, KAZUYUKI HAMADA, YUSUKE AOKI, NORIYUKI MASAKI, KOYA OBARA, ANTON BARANOV, MICHAEL BOUVET, TAKUYA TSUNODA and ROBERT M. HOFFMAN

  Cancer Genomics & Proteomics November 2022, 19 (6) 683-691; DOI: https://doi.org/10.21873/cgp.20351
• Open Access

  TMED9 Expression Level as a Biomarker of Epithelial Ovarian Cancer Progression and Prognosis

  GWAN HEE HAN, HEE YUN, JOON-YONG CHUNG, JAE-HOON KIM and HANBYOUL CHO

  Cancer Genomics & Proteomics November 2022, 19 (6) 692-702; DOI: https://doi.org/10.21873/cgp.20352
• Open Access

  Sex Hormone-regulated CMG2 Is Involved in Breast and Prostate Cancer Progression

  ZIQIAN FANG, CHARLOTTE KILLICK, CERITH HALFPENNY, NATASHA FREWER, KATHRYN A. FREWER, FIONA RUGE, WEN G. JIANG and LIN YE

  Cancer Genomics & Proteomics November 2022, 19 (6) 703-710; DOI: https://doi.org/10.21873/cgp.20353
• Open Access

  Novel TPR::ROS1 Fusion Gene Activates MAPK, PI3K and JAK/STAT Signaling in an Infant-type Pediatric Glioma

  LILY DELAND, SIMON KEANE, THOMAS OLSSON BONTELL, HENRIK FAGMAN, HELENE SJÖGREN, ANDERS E. LIND, HELENA CARÉN, MAGNUS TISELL, JONAS A. NILSSON, KATARINA EJESKÄR, MAGNUS SABEL and FRIDA ABEL

  Cancer Genomics & Proteomics November 2022, 19 (6) 711-726; DOI: https://doi.org/10.21873/cgp.20354
• Open Access

  Biomarker Expression Profiling in Cervix Carcinoma Biopsies Unravels WT1 as a Target of Artesunate

  MOHAMED E. M. SAEED, CANDELA CIVES-LOSADA and THOMAS EFFERTH

  Cancer Genomics & Proteomics November 2022, 19 (6) 727-739; DOI: https://doi.org/10.21873/cgp.20355
• Open Access

  Derivative Chromosome 3 Loss from t(3;6)(q12;q14) Followed by Differential VHL Mutations Underlie Multifocal ccRCC

  KOSUKE MIZUTANI, SHIGEAKI YOKOI, SEIYA SAWADA, IPPEI SAKAMOTO, KOJI KAMEYAMA, SHINGO KAMEI, KOUSEKI HIRADE, SEIJI SUGIYAMA, KENGO MATSUNAGA, TETSUYA YAMADA, YASUTAKA KATO, HIROSHI NISHIHARA, SATOSHI ISHIHARA and TAKASHI DEGUCHI

  Cancer Genomics & Proteomics November 2022, 19 (6) 740-746; DOI: https://doi.org/10.21873/cgp.20356
• Open Access

  Mesonephric-like Carcinosarcoma of the Uterine Corpus: Clinicopathological, Molecular and Prognostic Characteristics in Comparison With Uterine Mesonephric-like Adenocarcinoma and Conventional Endometrial Carcinosarcoma

  SUJIN PARK, EUNHYANG PARK and HYUN-SOO KIM

  Cancer Genomics & Proteomics November 2022, 19 (6) 747-760; DOI: https://doi.org/10.21873/cgp.20357
• Open Access

  Identification of a Novel Long Non-coding RNA, lnc-ATMIN-4:2, and its Clinicopathological and Prognostic Significance in Advanced Gastric Cancer

  EOJIN KIM, HYUNJIN KIM, MIN-KYUNG YEO, CHUL HWAN KIM, JOO YOUNG KIM, SUNGSOO PARK, HYUN-SOO KIM and YANG-SEOK CHAE

  Cancer Genomics & Proteomics November 2022, 19 (6) 761-772; DOI: https://doi.org/10.21873/cgp.20358